High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS?

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

(2010) Michael Knauer et al.   BREAST CANCER RESEARCH AND TREATMENT

Is quantitative oestrogen receptor expression useful in the evaluation of the clinical prognosis? Analysis of a homogeneous series of 797 patients with prospective determination of the ER status using simultaneous EIA and IHC

(2010) Chafika Mazouni et al.   EUROPEAN JOURNAL OF CANCER

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer

(2009) Katrine L. Henriksen et al.   ACTA ONCOLOGICA

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy

(2009) Filippo Montemurro et al.   ENDOCRINE-RELATED CANCER

Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer

(2009) Philippe L. Bedard et al.   Nature Reviews Clinical Oncology

Gene-Expression Signatures in Breast Cancer

(2009) Christos Sotiriou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II

(2009) Emily Cox et al.   VALUE IN HEALTH

Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part I

(2009) Marc L. Berger et al.   VALUE IN HEALTH

Fulvestrant: Expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer

(2008) Stephen Chia et al.   BREAST

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

(2008) Beat Thürlimann et al.   BREAST CANCER RESEARCH AND TREATMENT

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

(2008) Stella Mook et al.   BREAST CANCER RESEARCH AND TREATMENT

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

(2008) Marco Colleoni et al.   BREAST CANCER RESEARCH AND TREATMENT

Validation of 70-gene prognosis signature in node-negative breast cancer

(2008) J. M. Bueno-de-Mesquita et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen Receptor Expression and Efficacy of Docetaxel-Containing Adjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: Results From a Pooled Analysis

(2008) Fabrice Andre et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy Use for Hormone Receptor–Positive, Lymph Node–Negative Breast Cancer

(2008) Michael J. Hassett et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

(2008) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

(2008) Lori J. Goldstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors—International Breast Cancer Study Group

(2008) Giuseppe Viale et al.   JOURNAL OF CLINICAL ONCOLOGY

Reflections on Medical Oncology: 25 Years of Clinical Trials—Where Have We Come and Where Are We Going?

(2007) Christopher M. Booth et al.   JOURNAL OF CLINICAL ONCOLOGY

Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials

(2007) Michele De Laurentiis et al.   JOURNAL OF CLINICAL ONCOLOGY